Bayview Legacy sells 50K Arteris shares under 10b5-1

Bayview Legacy, LLC, a 10% owner of Arteris, Inc., reported open-market sales of a total of 50,000 shares of common stock over two days.

Rhea-AI Filing Summary

Bayview Legacy, LLC, a 10% owner of Arteris, Inc., reported open-market sales of a total of 50,000 shares of common stock over two days. On March 9, 2026, it sold 41,000 shares at a weighted average price of $14.2104 per share, and on March 10, 2026 it sold 9,000 shares at a weighted average price of $14.6630. The filing states these trades were made under a pre-arranged Rule 10b5-1 trading plan adopted by K. Charles Janac as manager of Bayview Legacy, LLC. Following the transactions, Bayview Legacy, LLC held 9,229,071 Arteris common shares indirectly.

Insider Trade Summary 10b5-1

Net Seller: 50,000 shares

Net Sell 2 txns

Insider Bayview Legacy, LLC

Role 10% Owner

Sold 50,000 shs ($715K)

Type	Security	Shares	Price	Value
Sale	Common Stock	9,000	$14.663	$132K
Sale	Common Stock	41,000	$14.2104	$583K

Holdings After Transaction: Common Stock — 9,229,071 shares (Indirect, See Footnote)

Footnotes (5)

1. F1. Transaction made pursuant to a 10b5-1 trading plan that was adopted by K. Charles Janac, as the manager of Bayview Legacy, LLC, on March 5, 2025.
2. F2. K. Charles Janac, in his individual capacity, has separately filed a Form 4 on the date hereof reporting the same transaction given his beneficial ownership of the reported security through Bayview Legacy, LLC, which he controls as its manager.
3. F3. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $14.00 to $14.63 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
4. F4. K. Charles Janac is the manager of Bayview Legacy, LLC and as such is deemed to have voting and dispositive power over the shares beneficially owned by Bayview Legacy, LLC.
5. F5. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $14.35 to $14.90 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

FAQ

What insider activity did Bayview Legacy, LLC report for Arteris (AIP)?

Bayview Legacy, LLC reported selling a total of 50,000 Arteris common shares in open-market transactions. The sales occurred over two days in March 2026 and were executed under a pre-arranged Rule 10b5-1 trading plan, according to the Form 4 footnotes.

On what dates did Bayview Legacy, LLC sell Arteris (AIP) shares and at what prices?

Bayview Legacy, LLC sold 41,000 shares on March 9, 2026 at a weighted average price of $14.2104, and 9,000 shares on March 10, 2026 at a weighted average price of $14.6630, all in open-market transactions.

How many Arteris (AIP) shares does Bayview Legacy, LLC hold after these sales?

After these transactions, Bayview Legacy, LLC is reported to hold 9,229,071 shares of Arteris common stock indirectly. This post-transaction balance is disclosed in the Form 4 and reflects holdings following the 50,000 shares sold in March 2026.

Were the Arteris (AIP) share sales by Bayview Legacy, LLC pre-planned?

Yes. The Form 4 footnotes state the sales were made pursuant to a Rule 10b5-1 trading plan adopted on March 5, 2025 by K. Charles Janac, as manager of Bayview Legacy, LLC, indicating the trades were pre-arranged rather than discretionary.

Who controls Bayview Legacy, LLC’s Arteris (AIP) holdings according to the Form 4?

The footnotes explain that K. Charles Janac is the manager of Bayview Legacy, LLC and is deemed to have voting and dispositive power over the Arteris shares beneficially owned by the LLC, clarifying who exercises control over these indirect holdings.

How are the sale prices for the Arteris (AIP) insider trades described?

The reported prices are weighted average sale prices. The footnotes note that individual trades on March 9 ranged from $14.00 to $14.63, and trades on March 10 ranged from $14.35 to $14.90, with full breakdowns available upon request.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/11/2026 - 04:51 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Bayview Legacy, LLC

(Last) (First) (Middle)

C/O ARTERIS, INC.

900 E. HAMILTON AVE., SUITE 300

(Street)

CAMPBELL CA 95008

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Arteris, Inc. [ AIP ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
03/09/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/09/2026		S(1)(2)		41,000	D	$14.2104(3)	9,238,071	I	See Footnote(4)
Common Stock	03/10/2026		S(1)(2)		9,000	D	$14.663(5)	9,229,071	I	See Footnote(4)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Transaction made pursuant to a 10b5-1 trading plan that was adopted by K. Charles Janac, as the manager of Bayview Legacy, LLC, on March 5, 2025.

2. K. Charles Janac, in his individual capacity, has separately filed a Form 4 on the date hereof reporting the same transaction given his beneficial ownership of the reported security through Bayview Legacy, LLC, which he controls as its manager.

3. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $14.00 to $14.63 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

4. K. Charles Janac is the manager of Bayview Legacy, LLC and as such is deemed to have voting and dispositive power over the shares beneficially owned by Bayview Legacy, LLC.

5. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $14.35 to $14.90 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Remarks:

	/s/ K. Charles Janac	03/11/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.